Senior Programmatic Management of Drug-Resistant TB; PMDT Advisor, DOS LEAP Global - Indonesia

Zemi Tek, LLC is a Woman-Owned, SBA-certified 8(a) Small Disadvantaged Business (SDB) based in the Washington, DC metro area. We have a strong record delivering innovative and high-quality solutions. Since 2007, Zemi Tek has provided technical assistance, project management, information technology (IT), knowledge management, monitoring and evaluation, training and learning development, and institutional support services.

Global Solutions Ventures (GSV) - a joint-venture partnership between Zemi Tek, LLC and Dexis Consulting Group - is implementing the Long-term Exceptional Technical Assistance Project (LEAP Global), a mechanism originally used by USAID to battle against infectious diseases such as malaria, HIV/AIDS, tuberculosis, neglected tropical diseases, and pandemic influenza. As of July 1, 2025, LEAP Global transitioned to the U.S. Department of State (DOS).

This initiative aims to address the complex human resource challenges faced by national infectious disease programs in the USA-supported countries. The intervention of this project is to hire and embed technical expert advisors and subject matter experts within government entities. By directly embedding the technical expertise within the national programs, LEAP provides long‑term, sustainable lifesaving support to empower host governments to lead and manage key aspects of their infectious disease portfolios and improve coordination between the U.S. Government and the host country.

The Senior PMDT Advisor will support Indonesia’s National TB Program (NTP) in delivering life‑saving humanitarian assistance service delivery in full alignment with the Presidential Executive Order directives. The Advisor’s primary focus is to provide technical support for direct service delivery, with a special emphasis on strengthening quality diagnostics and treatment services for TB patients through expert assistance in the programmatic management of drug‑resistant TB.

The Advisor will support the NTP in the effective adoption and implementation of life‑saving interventions for TB, with a focus on the detection, treatment and prevention of TB and M/XDR‑TB. The Advisor will identify programmatic bottlenecks and facilitate solutions through coordinated technical support, working closely with the National TB Program activities and the Global Fund. The Advisor will provide daily support to the NTP on all drug‑resistant TB issues collaborate closely with the U.S

Department of State (DoS) Health Assistance Unit in Indonesia. The Advisor will be based at the National TB Program within Indonesia’s Ministry of Health (MOH). The Advisor will receive directions from the National TB Program Manager, who will serve as the Onsite Manager. The Advisor will report to the U.S. Department of State Health Foreign Assistance Unit in Indonesia on a weekly and monthly basis.

• Serve as an expert advisor on programmatic components of drug‑resistant TB (DR‑TB) program.
• Provide guidance and expert opinion on the DR‑TB cascade of care, from detection to treatment initiation and support, for both adults and children.
• Assist the NTP with effective supervision and capacity building for DR‑TB sites, including mentorship, cohort monitoring, quality improvement tools, and improved supervisory arrangements to enhance the consistency and quality of clinical practice in PMDT.
• Support the development of a national plan for expanding DR‑TB treatment sites.
• Review policy options for new regimens, staying current on global updates for new drug (ND) shortened treatment regimen (STR), to ensure early adoption of international guidelines.
• Build NTP capacity for the introduction, implementation and scale‑up of the new DR‑TB drug regimens, including developing training curricula, guidelines, and standard operating procedures (SOPs).
• Analyze factors underlying suboptimal PMDT performance and support the NTP in planning and implementing strategic…